Lung Screening Could Reduce Lung Cancer Deaths
Lung cancer is the leading cause of cancer-related mortality in the UK. Approximately three quarters of patients are diagnosed at a late stage. If detected early, seven out of ten patients could survive for a year or more. It is thus important to to introduce early detection strategies that could help ensure early treatment delivery to patients before they reach an advanced stage of the disease.
See also: NSNs in Lung Cancer Can Be Managed With Annual CT Scan
This study evaluated the long-term psychosocial outcomes of CT screening for lung cancer. More than 4000 men and women aged 50-75 years and at high risk of lung cancer were included in the study. Study participants were assessed two weeks into the study and two years later. Emotional responses to CT lung screening were assessed using measures such as cancer distress, anxiety, depression and satisfaction.
Findings showed that more participants from the group that didn't receive scans were dissatisfied with their decision to participate in the trial. Cancer distress was found to be higher in women, participants under the age of 65 and current smokers, regardless of group allocation.
Study researchers conclude: “Sometimes, fear of medical procedures and the results they might bring can prevent people from seeking life-saving tests. However, what our trial shows is that CT lung cancer screening actually has no long-term negative psychosocial impact on patients, making it an excellent tool for catching lung cancer earlier when there is a better chance of survival.”
Image Credit: Wikimedia Commons
Published on : Mon, 1 Aug 2016
The enlightened choice for high-field MRI ECHELON Smart is Hitachi’s smart MRI concept which combines ‘SmartQUALITY’ for superb clinical images and sophisticated applications, ‘SmartSPEED’ for reduced examination time, ‘SmartCOMFORT’ for an extraordinary...
UltraDrape is an innovative dressing designed for use during Ultrasound-Guided Peripheral Intravenous (UGPIV) that provides dual-action barrier and securement in one.
The Next Evolution in Ultrasound, designed for high expectations ARIETTA 850 ultrasound platform responds to high expectations to answer the ever increasing demands of medical professionals. ARIETTA 850’s fundamental performance has been refined...
A breakthrough in biopsy efficiency The Brevera system streamlines the entire breast biopsy process from start to finish – with real-time imaging for instant verification and automated post-biopsy specimen handling. This has the potential to...
Open high-field efficiency with patient-centric architecture OASIS™ is a new generation of MR systems, providing a high degree of diagnostic confidence and extraordinary patient comfort. With this unique scanner, Hitachi combines best high-field performance...